A common acne medicine called minocycline can reduce the rate of multiple sclerosis progression in patients who are at early stages of [...]
Most people who care for multiple sclerosis (MS) patients are happy to be caregivers, but they admit that their own emotional and physical [...]
Multiple sclerosis patients who benefited from Ocrevus (ocrelizumab) in two Phase 3 clinical trials continued to benefit when they [...]
Young multiple sclerosis (MS) patients who engage in physical activity can relieve symptoms of depression, concludes a Canadian study [...]
Long-term treatment for up to 12o weeks, with the investigational drug Ozanimod (RPC-1063), found to be effective and safe in patients [...]
Multiple sclerosis patients who start Rituxan (rituximab) treatment are three times more likely to have unchanged or improved brain-scan [...]
Cladribine tablets reduced relapsing multiple sclerosis patients’ annual relapse rate by 55 to 57 percent, depending on the dose, [...]
Older patients with secondary progressive multiple sclerosis (SPMS) as well as older relapsing patients whose MS has been inactive after [...]
Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple [...]
People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression, research presented [...]